Future life expectancy in Europe taking into account the impact of smoking, obesity and alcohol

  1. Fanny Janssen  Is a corresponding author
  2. Anastasios Bardoutsos
  3. Shady El Gewily
  4. Joop De Beer
  1. Netherlands Interdisciplinary Demographic Institute (NIDI) & Dept of Demography, Faculty of Spatial Sciences, University of Groningen, Netherlands
  2. Faculty of Spatial Sciences, University of Groningen, Netherlands

Abstract

Introduction: In Europe, women can expect to live on average 82 years, and men 75 years. Forecasting how life expectancy will develop in the future is essential for society. Most forecasts rely on a mechanical extrapolation of past mortality trends, which leads to unreliable outcomes because of temporal fluctuations in the past trends due to lifestyle 'epidemics'.

Methods: We project life expectancy for 18 European countries by taking into account the impact of smoking, obesity, and alcohol on mortality, and the mortality experiences of forerunner populations.

Results: We project that life expectancy in these 18 countries will increase from, on average, 83.4 years for women and 78.3 years for men in 2014 to 92.8 years for women and 90.5 years for men in 2065. Compared to others (Lee-Carter, Eurostat, United Nations), we project higher future life expectancy values and more realistic differences between countries and sexes.

Conclusions: Our results imply longer individual lifespans, and more elderly in society.

Funding: Netherlands Organisation for Scientific Research (NWO) (grant no. 452-13-001).

Data availability

Some of our original data regarding lifestyle-attributable mortality were based on previous publications, which, in turn, used data that are openly available. The all-cause mortality data and the exposure data can be obtained through the Human Mortality Database. We have provided source data files for all our tables and figures. These comprise the numerical data that are represented in the different figures, and the output on which the different tables are based. In addition, one excel file with all the final numerical / output data that were used as input for the tables and figures will be made available at the Open Science Framework: https://osf.io/ghu45/. In addition, we will upload there the underlying observed age-specific mortality rates (all-cause mortality, non-lifestyle-attributable mortality, lifestyle-attributable mortality) as well as the adjusted and projected age-specific mortality rates (medians and 90% and 95% projection intervals). The different R codes used for the different steps of the data analyses will be shared - as well - through the Open Science Framework link above.

Article and author information

Author details

  1. Fanny Janssen

    NA, Netherlands Interdisciplinary Demographic Institute (NIDI) & Dept of Demography, Faculty of Spatial Sciences, University of Groningen, The Hague, Netherlands
    For correspondence
    janssen@nidi.nl
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3110-238X
  2. Anastasios Bardoutsos

    Demography Department, Faculty of Spatial Sciences, University of Groningen, Groningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  3. Shady El Gewily

    Demography Department, Faculty of Spatial Sciences, University of Groningen, Groningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  4. Joop De Beer

    NA, Netherlands Interdisciplinary Demographic Institute (NIDI) & Dept of Demography, Faculty of Spatial Sciences, University of Groningen, The Hague, Netherlands
    Competing interests
    The authors declare that no competing interests exist.

Funding

the Netherlands Organisation for Scientific Research (Innovational Research Incentives Scheme Vici,452-13-001)

  • Fanny Janssen
  • Anastasios Bardoutsos
  • Shady El Gewily

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Janssen et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,121
    views
  • 256
    downloads
  • 17
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Fanny Janssen
  2. Anastasios Bardoutsos
  3. Shady El Gewily
  4. Joop De Beer
(2021)
Future life expectancy in Europe taking into account the impact of smoking, obesity and alcohol
eLife 10:e66590.
https://doi.org/10.7554/eLife.66590

Share this article

https://doi.org/10.7554/eLife.66590

Further reading

    1. Cancer Biology
    2. Epidemiology and Global Health
    Chelsea L Hansen, Cécile Viboud, Lone Simonsen
    Research Article

    Cancer is considered a risk factor for COVID-19 mortality, yet several countries have reported that deaths with a primary code of cancer remained within historic levels during the COVID-19 pandemic. Here, we further elucidate the relationship between cancer mortality and COVID-19 on a population level in the US. We compared pandemic-related mortality patterns from underlying and multiple cause (MC) death data for six types of cancer, diabetes, and Alzheimer’s. Any pandemic-related changes in coding practices should be eliminated by study of MC data. Nationally in 2020, MC cancer mortality rose by only 3% over a pre-pandemic baseline, corresponding to ~13,600 excess deaths. Mortality elevation was measurably higher for less deadly cancers (breast, colorectal, and hematological, 2–7%) than cancers with a poor survival rate (lung and pancreatic, 0–1%). In comparison, there was substantial elevation in MC deaths from diabetes (37%) and Alzheimer’s (19%). To understand these differences, we simulated the expected excess mortality for each condition using COVID-19 attack rates, life expectancy, population size, and mean age of individuals living with each condition. We find that the observed mortality differences are primarily explained by differences in life expectancy, with the risk of death from deadly cancers outcompeting the risk of death from COVID-19.

    1. Epidemiology and Global Health
    Jie Liang, Yang Pan ... Fanfan Zheng
    Research Article

    Background:

    The associations of age at diagnosis of breast cancer with incident myocardial infarction (MI) and heart failure (HF) remain unexamined. Addressing this problem could promote understanding of the cardiovascular impact of breast cancer.

    Methods:

    Data were obtained from the UK Biobank. Information on the diagnosis of breast cancer, MI, and HF was collected at baseline and follow-ups (median = 12.8 years). The propensity score matching method and Cox proportional hazards models were employed.

    Results:

    A total of 251,277 female participants (mean age: 56.8 ± 8.0 years), of whom 16,241 had breast cancer, were included. Among breast cancer participants, younger age at diagnosis (per 10-year decrease) was significantly associated with elevated risks of MI (hazard ratio [HR] = 1.36, 95% confidence interval [CI] 1.19–1.56, p<0.001) and HF (HR = 1.31, 95% CI 1.18–1.46, p<0.001). After propensity score matching, breast cancer patients with younger diagnosis age had significantly higher risks of MI and HF than controls without breast cancer.

    Conclusions:

    Younger age at diagnosis of breast cancer was associated with higher risks of incident MI and HF, underscoring the necessity to pay additional attention to the cardiovascular health of breast cancer patients diagnosed at younger age to conduct timely interventions to attenuate the subsequent risks of incident cardiovascular diseases.

    Funding:

    This study was supported by grants from the National Natural Science Foundation of China (82373665 and 81974490), the Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences (2021-RC330-001), and the 2022 China Medical Board-open competition research grant (22-466).